Home > slashdot > Pharma Marketing Faces a Character-Count Conundrum

Pharma Marketing Faces a Character-Count Conundrum

March 13th, 2010 03:47 admin Leave a comment Go to comments

this_boat_is_real writes “There’s growing concern over how pharmaceutical companies use social media and the Internet to market their products. Last November, the US Food and Drug Administration held a hearing on the topic, and many were worried over how marketing mediums such as Twitter — which has a 140-character limit on text — can sufficiently disclose drug risks.” Here’s the FDA’s announcement about last year’s hearings, which includes links to an archive of presentations as well as a video record of the meeting.

Source: Pharma Marketing Faces a Character-Count Conundrum

Related Articles:

  1. Fired Techie Created Virtual Chaos At Pharma Co.
  2. How Big Pharma Hooked America On Legal Heroin
  3. Big Pharma Presses US To Quash Cheap Drug Production In India
  4. Why Snapchat and Its Ilk Face a Revenue Conundrum
  5. Ross Ulbricht Faces New Drug Charges
blog comments powered by Disqus
YOYOYOOYOYOYO